Search News

Corporate Industry Technology Medical Updates

heart transplant

Corporate
MoyoAssist® Extra-VAD® Introduces Fully Magnetically Levitated Extracorporeal Heart Support Technology in China 2024-06-28
Corporate
MoyoAssist® Launched! The Mid-to-Short-Term MCS Forum and Extra-VAD Clinical Technology Transformation Results Conference Successfully Held 2024-06-24
Corporate
NMPA grants approval to MoyoAssist® China's first full maglev extracorporeal VAD 2024-05-14
Medical Updates
The FIRST transseptal cannulation treatment via MoyoAssist Extra-VAD 2022-08-24
Corporate
Happy 5th Anniversary to magAssist!!! 2022-05-12
Industry
Behind the World's First Pig Heart Transplant - What Have We Learned? 2022-01-14
Corporate
magAssist was awarded the title of "Venture 100 Future Unicorn" 2021-12-17
Medical Updates
Professor Ping Li "Extra-VAD, could be a greater life-support solution for Bridging to Heart Transplantation" 2021-07-30
Medical Updates
The "Extra-VAD" jointly developed by Wuhan Union Medical College and magAssist Inc. was put into clinical use 2021-07-21
Corporate
magAssist's extracorporeal ventricular assist device Debuts at 2021 China International Heart Failure Conference 2021-07-16

Tabs： heart disease, extracorporeal ventricular assist device, medtech Innovator, BreathMo, end-stage heart failure, minimally invasive pVADs, clinical scenarios, innovative medical device enterprises in China, Heart Failure Treatment, Po-Lin Hsu,